Comment on "Clinical evaluation of fludeoxyglucosepositron emission tomography magnetic resonance imaging ([18F]FDG PET-MRI) and fludeoxyglucosepositron emission tomography computed tomography ([18F]FDG PET-CT) for lymph node assessment in head and neck squamous cell carcinoma".

S S Sah, A Kumbhalwar